Targeted eradication of EBV-positive cancer cells by CRISPR/dCas9-mediated EBV reactivation in combination with ganciclovir, 2024, Sugiokto
Discussion in 'Other health news and research' started by Mij, Jun 19, 2024.
Discussion in 'Other health news and research' started by Mij, Jun 19, 2024.